{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:53:47Z","timestamp":1785336827797,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T00:00:00Z","timestamp":1156464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1038\/sj.eye.6702542","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T19:09:49Z","timestamp":1156532989000},"page":"179-183","source":"Crossref","is-referenced-by-count":38,"title":["The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension"],"prefix":"10.1038","volume":"22","author":[{"given":"E S","family":"Arcieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P T P","family":"Pierre Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T H","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V P","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,25]]},"reference":[{"key":"BF6702542_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1350-9462(97)00003-7","volume":"17","author":"A Alm","year":"1998","unstructured":"Alm A . Prostaglandin derivates as ocular hypotensive agents. Prog Retin Eye Res 1998; 17: 291\u2013312.","journal-title":"Prog Retin Eye Res"},{"key":"BF6702542_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/13543784.10.4.679","volume":"10","author":"C Linden","year":"2001","unstructured":"Linden C . Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin Investig Drugs 2001; 10: 679\u2013694.","journal-title":"Expert Opin Investig Drugs"},{"key":"BF6702542_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1345\/aph.1A178","volume":"36","author":"CL Alexander","year":"2002","unstructured":"Alexander CL, Miller SJ, Abel SR . Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann Pharmacother 2002; 36: 504\u2013511.","journal-title":"Ann Pharmacother"},{"key":"BF6702542_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0039-6257(01)00286-7","volume":"47","author":"RL Stamper","year":"2002","unstructured":"Stamper RL, Wigginton SA, Higginbotham EJ . Primary drug treatment for glaucoma: beta-blockers versus other medications. Surv Ophthalmol 2002; 47: 63\u201373.","journal-title":"Surv Ophthalmol"},{"key":"BF6702542_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","volume":"135","author":"WC Stewart","year":"2003","unstructured":"Stewart WC, Kolker AE, Stewart JA, Leech J, Jackson AL . Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol 2003; 135: 314\u2013320.","journal-title":"Am J Ophthalmol"},{"key":"BF6702542_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00002512-199915050-00005","volume":"15","author":"CB Camras","year":"1999","unstructured":"Camras CB, Toris CB, Tamesis RR . Efficacy and adverse effects of medications used in the treatment of glaucoma. Drugs Aging 1999; 15: 377\u2013388.","journal-title":"Drugs Aging"},{"key":"BF6702542_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","volume":"135","author":"RK Parrish","year":"2003","unstructured":"Parrish RK, Palmberg P, Sheu WP . A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135: 688\u2013703.","journal-title":"Am J Ophthalmol"},{"key":"BF6702542_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archopht.123.2.186","volume":"123","author":"ES Arcieri","year":"2005","unstructured":"Arcieri ES, Santana A, Rocha FN, Guapo GL, Costa VP . Blood\u2013aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial. Arch Ophthalmol 2005; 123: 186\u2013192.","journal-title":"Arch Ophthalmol"},{"key":"BF6702542_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00061198-200008000-00006","volume":"9","author":"MC Lima","year":"2000","unstructured":"Lima MC, Paranhos Jr A, Salim S, Honkanen R, Devgan L, Wand M et al. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost. J Glaucoma 2000; 9: 317\u2013321.","journal-title":"J Glaucoma"},{"key":"BF6702542_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archopht.119.3.387","volume":"119","author":"K Miyake","year":"2001","unstructured":"Miyake K, Ota I, Ibaraki N, Akura J, Ichihashi S, Shibuya Y et al. Enhanced disruption of the blood\u2013aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 2001; 119: 387\u2013394.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"BF6702542_CR11","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/S0039-6257(02)00294-1","volume":"47","author":"K Miyake","year":"2002","unstructured":"Miyake K, Ibaraki N . Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002; 47 (Suppl 1): S203\u2013S218.","journal-title":"Surv Ophthalmol"},{"key":"BF6702542_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0161-6420(98)92977-3","volume":"105","author":"RE Warwar","year":"1998","unstructured":"Warwar RE, Bullock JD, Ballal D . Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998; 105: 263\u2013268.","journal-title":"Ophthalmology"},{"key":"BF6702542_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0002-9394(98)00127-5","volume":"126","author":"RS Ayyala","year":"1998","unstructured":"Ayyala RS, Cruz DA, Margo CE, Harman LE, Pautler SE, Misch DM et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol 1998; 126: 602\u2013604.","journal-title":"Am J Ophthalmol"},{"key":"BF6702542_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0002-9394(01)01412-X","volume":"133","author":"M Wand","year":"2002","unstructured":"Wand M, Shields BM . Cystoid macular edema in the era of ocular hypotensive lipids. Am J Ophthalmol 2002; 133: 393\u2013397.","journal-title":"Am J Ophthalmol"},{"key":"BF6702542_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0161-6420(99)00528-X","volume":"106","author":"SE Moroi","year":"1999","unstructured":"Moroi SE, Gottfredsdottir MS, Schteingart MT, Elner SG, Lee CM, Schertzer RM et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999; 106: 1024\u20131029.","journal-title":"Ophthalmology"},{"key":"BF6702542_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0021-5155(02)00622-6","volume":"47","author":"K Watanabe","year":"2003","unstructured":"Watanabe K, Hayasaka S, Hayasaka Y, Nagaki Y, Watanabe K . Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications. Jpn J Ophthalmol 2003; 47: 110\u2013112.","journal-title":"Jpn J Ophthalmol"},{"key":"BF6702542_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/archopht.117.1.34","volume":"117","author":"K Miyake","year":"1999","unstructured":"Miyake K, Ota I, Maekubo K, Ichihashi S, Miyake S . Latanoprost accelerates disruption of the blood\u2013aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 1999; 117: 34\u201340.","journal-title":"Arch Ophthalmol"},{"key":"BF6702542_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00061198-200106000-00016","volume":"10","author":"M Furuichi","year":"2001","unstructured":"Furuichi M, Chiba T, Abe K, Kogure S, Iijima H, Tsukahara S et al. Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood\u2013ocular barrier. J Glaucoma 2001; 10: 233\u2013236.","journal-title":"J Glaucoma"},{"key":"BF6702542_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1034\/j.1600-0420.1999.770214.x","volume":"77","author":"SL Smith","year":"1999","unstructured":"Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC . The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension. Acta Ophthalmol Scand 1999; 77: 189\u2013192.","journal-title":"Acta Ophthalmol Scand"},{"key":"BF6702542_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000079472","volume":"218","author":"M Cellini","year":"2004","unstructured":"Cellini M, Caramazza R, Bonsanto D, Bernabini B, Campos EC . Prostaglandin analogs and blood\u2013aqueous barrier integrity: a flare cell meter study. Ophthalmologica 2004; 218: 312\u2013317.","journal-title":"Ophthalmologica"},{"key":"BF6702542_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9394(98)00071-3","volume":"126","author":"RD Fechtner","year":"1998","unstructured":"Fechtner RD, Khouri AS, Zimmerman TJ, Bullock J, Feldman R, Kulkarni P et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol 1998; 126: 37\u201341.","journal-title":"Am J Ophthalmol"},{"key":"BF6702542_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/bjo.82.4.404","volume":"82","author":"I Widengard","year":"1998","unstructured":"Widengard I, Maepea O, Alm A . Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood\u2013aqueous barrier permeability. Br J Ophthalmol 1998; 82: 404\u2013406.","journal-title":"Br J Ophthalmol"},{"key":"BF6702542_CR23","first-page":"259","volume":"37","author":"Y Hotehama","year":"1993","unstructured":"Hotehama Y, Mishima HK . Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2 alpha-isopropyl ester analogues for glaucoma treatment. Jpn J Ophthalmol 1993; 37: 259\u2013269.","journal-title":"Jpn J Ophthalmol"},{"key":"BF6702542_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/bjo.81.5.370","volume":"81","author":"C Linden","year":"1997","unstructured":"Linden C, Nuija E, Alm A . Effects on IOP restoration and blood\u2013aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension. Br J Ophthalmol 1997; 81: 370\u2013372.","journal-title":"Br J Ophthalmol"},{"key":"BF6702542_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1055\/s-2004-81361","volume":"221","author":"A Viestenz","year":"2004","unstructured":"Viestenz A, Martus P, Schlotzer-Schrehardt U, Langenbucher A, Mardin CY . Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness\u2014a cross-sectional study on 403 eyes. Klin Monatsbl Augenheilkd 2004; 221: 753\u2013756.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BF6702542_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000303213","volume":"134","author":"H Goldmann","year":"1957","unstructured":"Goldmann H, Schmidt T . Applanation tonometry. Ophthalmologica 1957; 134: 221\u2013242.","journal-title":"Ophthalmologica"},{"key":"BF6702542_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archopht.122.1.17","volume":"122","author":"LW Herndon","year":"2004","unstructured":"Herndon LW, Weizer JS, Stinnett SS . Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004; 122: 17\u201321.","journal-title":"Arch Ophthalmol"},{"key":"BF6702542_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/archopht.122.9.1270","volume":"122","author":"CY Shih","year":"2004","unstructured":"Shih CY, Graff Zivin JS, Trokel SL, Tsai JC . Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 2004; 122: 1270\u20131275.","journal-title":"Arch Ophthalmol"},{"key":"BF6702542_CR29","first-page":"346","volume":"34","author":"M Sawa","year":"1990","unstructured":"Sawa M . Clinical application of laser flare-cell meter. Jpn J Ophthalmol 1990; 34: 346\u2013363.","journal-title":"Jpn J Ophthalmol"},{"key":"BF6702542_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/exer.1996.0119","volume":"63","author":"SY Yousufzai","year":"1996","unstructured":"Yousufzai SY, Ye Z, Abdel-Latif AA . Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res 1996; 63: 305\u2013310.","journal-title":"Exp Eye Res"},{"key":"BF6702542_CR31","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"R van der Valk","year":"2005","unstructured":"van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH . Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005; 112: 1177\u20131185.","journal-title":"Ophthalmology"},{"key":"BF6702542_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0161-6420(00)00531-5","volume":"108","author":"JH Lass","year":"2001","unstructured":"Lass JH, Eriksson GL, Osterling L, Simpson CV, Latanoprost Corneal Effects Study Group. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: a double-masked, randomized, one-year study. Ophthalmology 2001; 108: 264\u2013271.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6702542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702542","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:27:10Z","timestamp":1684412830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6702542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,25]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["BF6702542"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6702542","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,25]]}}}